Logo for Circio Holding

Circio Holding Investor Relations Material

Latest events

Logo for Circio Holding

R&D Update

Circio Holding
Logo for Circio Holding

Biologics World Nordics 2025 Presentation

5 Mar, 2025
Logo for Circio Holding

RNA Leaders Europe Congress Presentation

5 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Circio Holding

Access all reports
Circio Holding ASA, formerly known as Targovax ASA, is a biotechnology company primarily engaged in the development of innovative circular RNA (circRNA) and immunotherapy medicines. The company has pioneered a distinctive circRNA platform, aiming to create novel circRNA medicines for a variety of applications including rare diseases, vaccines, cancer treatments, protein replacement therapies, and cell therapy. The company is headquartered in Oslo, Norway, and its shares are listed on the Oslo Stock Exchange under the ticker symbol CRNA.